Trial Profile
Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury A Follow-up Study of an International Randomised Controlled Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2023
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Traumatic brain injuries
- Focus Therapeutic Use
- 01 Oct 2023 Status changed from recruiting to completed.
- 23 Aug 2021 Planned End Date changed from 31 Dec 2020 to 31 Dec 2022.
- 23 Aug 2021 Planned primary completion date changed from 1 Jul 2020 to 1 Jul 2022.